143 related articles for article (PubMed ID: 8053701)
1. Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies.
Tokura Y; Yamanaka K; Wakita H; Kurokawa S; Horiguchi D; Usui A; Sayama S; Takigawa M
Arch Dermatol; 1994 Aug; 130(8):1036-41. PubMed ID: 8053701
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous Involution of Congenital Melanocytic Nevus With Halo Phenomenon.
Lee NR; Chung HC; Hong H; Lee JW; Ahn SK
Am J Dermatopathol; 2015 Dec; 37(12):e137-9. PubMed ID: 26588343
[TBL] [Abstract][Full Text] [Related]
3. The immune response in halo nevi.
Zeff RA; Freitag A; Grin CM; Grant-Kels JM
J Am Acad Dermatol; 1997 Oct; 37(4):620-4. PubMed ID: 9344203
[TBL] [Abstract][Full Text] [Related]
4. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.
Musette P; Bachelez H; Flageul B; Delarbre C; Kourilsky P; Dubertret L; Gachelin G
J Immunol; 1999 Feb; 162(3):1789-94. PubMed ID: 9973443
[TBL] [Abstract][Full Text] [Related]
6. Halo giant congenital melanocytic nevus: in vitro immunologic studies.
Berman B; Shaieb AM; France DS; Altchek DD
J Am Acad Dermatol; 1988 Nov; 19(5 Pt 2):954-60. PubMed ID: 3057001
[TBL] [Abstract][Full Text] [Related]
7. [Halo nevus. In situ study using monoclonal antibodies].
Vignale RA; Paciel J; Bruno J; Calandría L; de Anda G
Med Cutan Ibero Lat Am; 1986; 14(1):13-7. PubMed ID: 2942737
[TBL] [Abstract][Full Text] [Related]
8. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus.
Bayer-Garner IB; Ivan D; Schwartz MR; Tschen JA
Clin Med Res; 2004 May; 2(2):89-97. PubMed ID: 15931341
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
[TBL] [Abstract][Full Text] [Related]
10. Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature.
Langer K; Konrad K
J Dermatol Surg Oncol; 1990 Apr; 16(4):377-80. PubMed ID: 2182687
[TBL] [Abstract][Full Text] [Related]
11. CD69 expression and tumour necrosis factor-alpha immunoreactivity in the inflammatory cell infiltrate of halo naevi.
Fernández-Herrera J; Fernández-Ruiz E; López-Cabrera M; García-Díez A; Sánchez-Madrid F; González-Amaro R
Br J Dermatol; 1996 Mar; 134(3):388-93. PubMed ID: 8731658
[TBL] [Abstract][Full Text] [Related]
12. Pigmentary regression in a giant nevocellular nevus: a case report and a review of the subject.
Zack LD; Stegmeier O; Solomon LM
Pediatr Dermatol; 1988 Aug; 5(3):178-83. PubMed ID: 3060869
[TBL] [Abstract][Full Text] [Related]
13. Granulomatous inflammation in nevi undergoing regression (halo phenomenon): a report of 6 cases.
Denianke KS; Gottlieb GJ
Am J Dermatopathol; 2008 Jun; 30(3):233-5. PubMed ID: 18496423
[TBL] [Abstract][Full Text] [Related]
14. Study of the immunophenotype of the inflammatory cells in melanomas with regression and halo nevi.
Botella-Estrada R; Kutzner H
Am J Dermatopathol; 2015 May; 37(5):376-80. PubMed ID: 25222195
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous onset of segmental vitiligo and a halo surrounding a congenital melanocytic naevus.
Hofmann UB; Bröcker EB; Hamm H
Acta Derm Venereol; 2009; 89(4):402-6. PubMed ID: 19688155
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous regression of congenital melanocytic nevi without evidence of the halo phenomenon.
Kageshita T; Inoue Y; Ono T
Dermatology; 2003; 207(2):193-5. PubMed ID: 12920373
[TBL] [Abstract][Full Text] [Related]
17. Association of giant congenital melanocytic nevus, halo nevus and vitiligo in a 75-year-old patient.
Silveira ML; Ferreira FR; Alvarenga ML; Mandelbaum SH
An Bras Dermatol; 2012; 87(2):288-91. PubMed ID: 22570035
[TBL] [Abstract][Full Text] [Related]
18. Unusual clinical presentation of regression in a congenital melanocytic nevus.
Arpaia N; Cassano N; Filotico R; Laricchia F; Vena GA
Dermatol Surg; 2005 Apr; 31(4):471-3. PubMed ID: 15871327
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
[No Abstract] [Full Text] [Related]
20. Characterization of the mononuclear infiltrate involved in regression of halo nevi.
Akasu R; From L; Kahn HJ
J Cutan Pathol; 1994 Aug; 21(4):302-11. PubMed ID: 7798386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
